Market Cap

BrightGene Bio-Medical Technology Co. Ltd Market Capitalization:

CN¥15.37 Billion

CNY as of July 1, 2024

US$2.11 Billion

business BrightGene Bio-Medical Technology Co. Ltd Company Profile

BrightGene Bio-Medical Technology Co. Ltd Main Stock Listing

SSE: 688166

Market Capitalization History of BrightGene Bio-Medical Technology Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of BrightGene Bio-Medical Technology Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥13.80 B 44.26%
Jan. 1, 2023 CN¥9.56 B -24.57%
Jan. 1, 2022 CN¥12.68 B -34.47%
Jan. 1, 2021 CN¥19.35 B 19.53%
Jan. 1, 2020 CN¥16.19 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

BrightGene Bio-Medical Technology Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

BrightGene Bio-Medical Technology Co. Ltd has the following listings and related stock indices.


Stock: SSE: 688166

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.